Stay updated with breaking news from Diffusion Pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN – Get Rating) was the target of a large decrease in short interest in May. As of May 31st, there was short interest totalling 6,400 shares, a decrease of 34.0% from the May 15th total of 9,700 shares. Currently, 0.3% of the company’s stock are sold short. Based on an average […]
StockNews.com began coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Wednesday. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Up 2.4 % Shares of Diffusion Pharmaceuticals stock opened at $3.60 on Wednesday. The firm has a market cap of $7.34 million, […]
Research Analysts’ new coverage for Wednesday, June 14th: BNP Paribas began coverage on shares of Agree Realty (NYSE:ADC). The firm issued an outperform rating and a $80.00 target price on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares […]
Research Analysts’ new coverage for Wednesday, June 14th: BNP Paribas began coverage on shares of Agree Realty (NYSE:ADC). The firm issued an outperform rating and a $80.00 target price on the stock. StockNews.com initiated coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). The firm issued a hold rating on the stock. StockNews.com assumed coverage on shares […]
StockNews.com assumed coverage on shares of Diffusion Pharmaceuticals (NASDAQ:DFFN – Get Rating) in a research note issued to investors on Tuesday morning. The firm issued a hold rating on the stock. Diffusion Pharmaceuticals Stock Performance Shares of NASDAQ:DFFN opened at $3.51 on Tuesday. Diffusion Pharmaceuticals has a 1 year low of $3.42 and a 1 […]